Your browser doesn't support javascript.
loading
Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41-BEVANEC randomized phase II study.
Walter, Thomas; Malka, David; Hentic, Olivia; Lombard-Bohas, Catherine; Le Malicot, Karine; Smith, Denis; Ferru, Aurélie; Assenat, Eric; Cadiot, Guillaume; Lievre, Astrid; Kurtz, Jean-Emmanuel; Dahan, Laetitia; Dubreuil, Olivier; Hautefeuille, Vincent; Lepere, Céline; Gangloff, Alice; Elhajbi, Farid; Coriat, Romain; Roquin, Guillaume; Bouarioua, Nadia; Granger, Victoire; Scoazec, Jean-Yves; Lepage, Côme.
Afiliação
  • Walter T; Department of Medical Oncology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France. Electronic address: thomas.walter@chu-lyon.fr.
  • Malka D; Gastrointestinal Oncology Department, Gustave Roussy Institute, Villejuif, France.
  • Hentic O; Gastroenterology-Pancreatology Department, Beaujon Hospital, PMAD, Clichy, France.
  • Lombard-Bohas C; Department of Medical Oncology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.
  • Le Malicot K; Fédération Francophone de Cancérologie Digestive, Dijon, France.
  • Smith D; Hepatogastroenterology and Digestive Oncology Department, Haut-Lévèque, University Hospital of Bordeaux, Pessac, France.
  • Ferru A; Pôle régional de cancérologie, University Hospital of Poitiers, Poitiers, France.
  • Assenat E; Medical Oncology Department, University Hospital St Eloi, Montpellier, France.
  • Cadiot G; Department of Hepatogastroenterology and Digestive Oncology, Robert Debré Hospital, University Hospital of Reims, Reims, France.
  • Lievre A; Service des maladies de l'appareil digestif, University Hospital of Pontchaillou, Rennes, France.
  • Kurtz JE; Oncology Department, Nouvel Hospital Civil, University Hospital of Strasbourg, Strasbourg, France.
  • Dahan L; Digestive Oncology Department, University Hospital Timone, Marseille, France.
  • Dubreuil O; Hepatogastroenterology and Digestive Oncology Department, Pitié Salpêtrière Hospital, Paris, France.
  • Hautefeuille V; Gastroenterology and Digestive Oncology, Amiens University Hospital, Amiens, France.
  • Lepere C; European Georges Pompidou Hospital, Paris, France.
  • Gangloff A; Gastroenterology Department, University Hospital of Rouen, Rouen, France.
  • Elhajbi F; Oncology Department, Oscar Lambret Center, Lille, France.
  • Coriat R; Gastroenterology Department, Cochin Hospital, Paris, France.
  • Roquin G; Gastroenterology & Digestive Oncology, University Hospital of Angers, Angers, France.
  • Bouarioua N; Service de gastroentérologie et oncologie digestive, hôpital Nord, Saint Priest en Jarez, France.
  • Granger V; Hepatogastroenterology Department, Michallon Hospital, University Hospital of Grenoble, Grenoble, France.
  • Scoazec JY; Gustave Roussy Cancer Campus, Department of Surgical and Molecular Pathology, Villejuif Cedex, France; Université Paris Saclay, Université Paris Sud XI, Faculté de Médecine de Bicêtre, Le Kremlin-Bicêtre, France.
  • Lepage C; Gastrointestinal Oncology Department, Gustave Roussy Institute, Villejuif, France; Gastroenterology & Digestive Oncology, University Hospital Le Bocage, Dijon, France.
Dig Liver Dis ; 50(2): 195-198, 2018 Feb.
Article em En | MEDLINE | ID: mdl-29258812

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Gástricas / Camptotecina / Protocolos de Quimioterapia Combinada Antineoplásica / Tumores Neuroendócrinos / Carcinoma Neuroendócrino / Bevacizumab / Neoplasias Intestinais Tipo de estudo: Clinical_trials Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Dig Liver Dis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Gástricas / Camptotecina / Protocolos de Quimioterapia Combinada Antineoplásica / Tumores Neuroendócrinos / Carcinoma Neuroendócrino / Bevacizumab / Neoplasias Intestinais Tipo de estudo: Clinical_trials Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Dig Liver Dis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2018 Tipo de documento: Article